Psychiatry

814 soru

Soru 621Soru →

A 34-year-old man is brought to the emergency department by paramedics after being found confused and severely agitated in his apartment. Beside him are empty bottles of tranylcypromine and fluoxetine. In the emergency department, he is delirious and thrashing violently. His temperature is 39.5°C (103.1°F), blood pressure is 170/105 mm Hg, and pulse is 135/min. Physical examination reveals pronounced diaphoresis, hyperreflexia, and sustained ankle clonus bilaterally. Shortly after the initial assessment, the patient develops a generalized tonic-clonic seizure.

The patient's electronic health record contains a legally executed medical power of attorney designating his long-term partner as his sole healthcare proxy. The partner is currently on an international flight and cannot be reached. The patient's biological parents, who were notified of the emergency by the landlord, arrive at the hospital. They declare themselves as his legal next-of-kin and demand that all medications be withheld, insisting he 'just needs to sleep it off without chemical interference.'

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Administer intravenous lorazepam immediately under the doctrine of implied consent

Cevap

The most appropriate next step is to administer intravenous lorazepam immediately under the doctrine of implied consent.
The patient is experiencing severe serotonin syndrome (precipitated by the overdose of an MAOI and an SSRI) complicated by a generalized tonic-clonic seizure. This is a life-threatening medical emergency requiring immediate pharmacological intervention with intravenous benzodiazepines (e.g., lorazepam) to control the seizures, agitation, and hyperthermia. In a life-threatening emergency where a patient lacks decision-making capacity and their legally appointed healthcare proxy is unreachable, physicians must provide necessary life-saving treatment under the doctrine of implied consent (the emergency exception to informed consent). The biological parents have no legal authority to direct care because a legally executed medical power of attorney supersedes the default state next-of-kin hierarchy. Therefore, the immediate administration of lorazepam is both medically essential and legally justified.

Adım Adım Çözüm

1
Diagnose the patient's acute clinical condition based on the presentation and history.
The patient has severe serotonin syndrome (due to MAOI and SSRI overdose) complicated by a generalized tonic-clonic seizure, which is a life-threatening medical emergency.
Accurate clinical diagnosis dictates the urgency and type of pharmacological intervention required.
2
Determine the appropriate legal decision-maker for the incapacitated patient.
The legally appointed healthcare proxy is unreachable. The biological parents present do not hold decision-making authority because the medical power of attorney supersedes the default next-of-kin hierarchy.
Identifying the legal surrogate is necessary for informed consent, but strict hierarchy rules apply in law.
3
Apply the appropriate medical ethics doctrine for an emergency situation where the proxy is absent.
The physician must apply the emergency exception to informed consent (implied consent) to immediately administer life-saving standard of care (intravenous lorazepam).
Delaying treatment in a rapidly deteriorating, life-threatening situation to find a proxy, or obeying unauthorized demands that cause harm, constitutes medical negligence.

Anahtar Kavram

Emergency Exception to Informed Consent and Surrogate Hierarchy
Soru 622Soru →

A 28-year-old pregnant woman at 14 weeks gestation is brought to the emergency department by her husband. Over the past week, she has been sleeping for only one to two hours a night, exhibiting rapid and pressured speech, and making impulsive, large financial investments that they cannot afford. Three weeks ago, she visited a different clinic reporting severe sadness, hypersomnia, and anhedonia, at which time fluoxetine monotherapy was initiated. She is currently taking fluoxetine and prenatal vitamins. When approached by the physician, she refuses any new medications or hospital admission, stating her high energy is a "divine gift for the baby" and demands to leave immediately. Which of the following are the most appropriate next steps in the management of this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Discontinue the fluoxetine immediately.; Assess her decision-making capacity and place an involuntary psychiatric hold if she is deemed a danger to herself or others.

Cevap

The most appropriate steps are to immediately discontinue the fluoxetine and to perform a formal assessment of her decision-making capacity, placing an involuntary hold if she is deemed a danger to herself.
The patient's presentation of markedly decreased need for sleep, pressured speech, and grandiose, impulsive behavior following the initiation of an SSRI is diagnostic of an antidepressant-induced manic episode. The essential first pharmacological step is to discontinue the offending agent (fluoxetine). Because the patient is exhibiting poor insight and potentially dangerous impulsivity but is refusing care, the physician must formally assess her decision-making capacity. If her mania has impaired her capacity and she poses a danger to herself or others, placing her on an involuntary psychiatric hold is the appropriate legal and ethical next step to ensure safety.

Adım Adım Çözüm

1
Identify the patient's current clinical syndrome and its likely trigger.
The patient is experiencing an acute manic episode, likely precipitated by the recent initiation of fluoxetine for depression (antidepressant-induced manic switch).
Recognizing the iatrogenic trigger is essential for deciding the most urgent pharmacological intervention.
2
Determine the immediate pharmacological management strategy.
The fluoxetine must be discontinued.
Continuing an antidepressant during an acute manic episode will prolong and worsen the manic symptoms. Antidepressant monotherapy is contraindicated in bipolar spectrum disorders.
3
Evaluate the ethical and legal obligations regarding her refusal of care.
A formal capacity assessment is required. If she lacks capacity due to mania and poses a danger to herself (e.g., severe financial ruin, lack of self-care), an involuntary hold is indicated.
While competent pregnant women have the right to refuse medical care even if it risks the fetus, acute mania often impairs decision-making capacity. Intervention must be based on her lack of capacity and risk of harm, not solely on fetal protection.

Anahtar Kavram

Management of antidepressant-induced mania and maternal-fetal ethics in psychiatric emergencies
Tahmini Süre:1m 15s
Soru 623Soru →

A 31-year-old man comes to the clinic accompanied by his husband due to daytime sleep attacks and episodes of sudden muscle weakness. Over the last 5 months, he has been sleeping 9 to 10 hours per night but still struggles to stay awake during his work as a financial analyst. He reports that when he laughs heartily at a joke, his knees buckle and he occasionally drops his briefcase, though he remains fully conscious. Last month, while falling asleep, he saw a terrifying shadowy figure in his room and was unable to move his limbs for approximately a minute. His medical history is notable for a manic episode at age 22, leading to a diagnosis of bipolar I disorder. He was previously taking valproate but discontinued it a year ago due to weight gain. He is currently taking only tranylcypromine, which was prescribed 2 months ago for an acute depressive episode. Vital signs are within normal limits. Physical examination is unremarkable. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 7.2 µU/mL (normal: 0.5-5.0 µU/mL) and a free thyroxine (T4) level of 1.2 ng/dL (normal: 0.9-1.7 ng/dL).

Which of the following is the most appropriate pharmacotherapy for this patient's sleep-related symptoms?

Cevabı ve açıklamayı göster

Cevap: Sodium oxybate

Cevap

Sodium oxybate
Sodium oxybate is an FDA-approved, highly effective treatment for both the excessive daytime sleepiness and cataplexy associated with Narcolepsy Type 1. It acts as a central nervous system depressant (via GABA-B and GHB receptors) to consolidate fragmented nighttime sleep. Crucially, in this complex patient, sodium oxybate does not carry serotonergic activity, meaning it can be safely co-administered with his current monoamine oxidase inhibitor (tranylcypromine) without causing serotonin syndrome. Furthermore, unlike activating antidepressants, it does not carry a high risk of precipitating a manic episode in a patient with bipolar I disorder who is currently off mood stabilizers.

Adım Adım Çözüm

1
Identify the primary diagnosis based on the clinical presentation.
The patient's excessive daytime sleepiness, cataplexy (muscle weakness triggered by laughter), hypnagogic hallucinations, and sleep paralysis are diagnostic of Narcolepsy Type 1.
Recognizing the full tetrad of narcolepsy symptoms differentiates it from other causes of fatigue, such as hypothyroidism or depression.
2
Evaluate the patient's current medication regimen and medical history for potential contraindications.
The patient has Bipolar I disorder not covered by a mood stabilizer, and is currently taking tranylcypromine, a monoamine oxidase inhibitor (MAOI).
Standard off-label cataplexy treatments (SSRIs/SNRIs) pose extreme risks in this specific patient, including manic switch and serotonin syndrome.
3
Select the appropriate therapy that safely addresses the core symptoms.
Sodium oxybate is chosen as the most appropriate pharmacotherapy.
It treats both excessive daytime sleepiness and cataplexy effectively without interacting with the MAOI or precipitating mania.

Anahtar Kavram

Management of Narcolepsy Type 1 in patients with psychiatric comorbidities and complex medication regimens.
Soru 624Soru →

On postoperative day 3 following an open reduction and internal fixation of a right tibial fracture, a 51-year-old male is evaluated by the on-call physician for acute, severe agitation and confusion. The fracture was sustained during a motor vehicle collision. The patient lives alone and a comprehensive medical history is unavailable. Current temperature is 38.7°C (101.7°F), pulse is 126/min, blood pressure is 168/102 mm Hg, and respirations are 22/min. On examination, the patient is profoundly diaphoretic and continuously attempts to pull out his intravenous catheter. When approached, he points frantically toward the ceiling and claims that swarms of insects are dropping onto his bed. Neurological examination reveals a coarse, bilateral resting tremor of the upper extremities. The surgical incision is clean, intact, and without erythema. Cardiopulmonary auscultation is unremarkable. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Intravenous administration of diazepam

Cevap

The most appropriate next step is the intravenous administration of a long-acting benzodiazepine, such as diazepam.
The patient's presentation of fever, marked autonomic hyperactivity (tachycardia, hypertension, diaphoresis), coarse resting tremor, and visual hallucinations occurring roughly 72 hours (postoperative day 3) after an unplanned hospital admission is the classic presentation of delirium tremens. Delirium tremens is a severe, life-threatening manifestation of alcohol withdrawal. Because patients often live alone and do not disclose their alcohol use history upon admission for trauma, the withdrawal syndrome unmasks itself a few days into their stay. The gold standard for treating severe alcohol withdrawal is the administration of benzodiazepines (e.g., diazepam, lorazepam, or chlordiazepoxide). These drugs enhance the inhibitory effect of GABA, counteracting the glutamate-driven excitatory state of withdrawal, thereby reducing agitation, stabilizing vital signs, and preventing withdrawal seizures.

Adım Adım Çözüm

1
Analyze the patient's timeline and physical exam findings.
The patient developed fever, severe autonomic hyperactivity (tachycardia, hypertension, diaphoresis), coarse tremor, and visual hallucinations ('insects') on postoperative day 3.
Recognizing the '48 to 96 hour' window after hospital admission is critical for identifying alcohol withdrawal in patients who have abruptly ceased covert drinking.
2
Establish the most likely diagnosis.
The clinical picture is pathognomonic for delirium tremens (severe alcohol withdrawal).
Alcohol acts as a CNS depressant by enhancing GABA and inhibiting glutamate. Abrupt cessation leads to a hyper-excitable state, manifesting as the symptoms seen in this patient.
3
Determine the optimal acute pharmacological management.
Select a medication that safely replaces the inhibitory effect of alcohol, which is a benzodiazepine.
Benzodiazepines stimulate GABA receptors, mitigating the severe withdrawal symptoms, correcting autonomic instability, and preventing fatal complications such as seizures.

Anahtar Kavram

Patients with undisclosed alcohol use disorder often present with delirium tremens (hallucinations, tremor, autonomic instability) 48 to 96 hours after hospital admission; first-line treatment is a benzodiazepine.
Soru 625Soru →

A 68-year-old man is brought to the clinic by his son for evaluation of cognitive decline. The son reports that his father's memory has worsened significantly over the past 4 months, which coincided with the unexpected death of his wife. The patient frequently misplaces his glasses and forgets the names of acquaintances. During the interview, the patient appears visibly distressed about his memory, stating, "My brain is completely useless now. I can't remember a single thing." When asked orientation questions and to perform a three-word delayed recall, he frequently answers "I don't know" with little initial effort. However, with gentle encouragement and extra time, he is able to correctly recall two of the three words. The patient also reports early morning awakenings, poor appetite, and a 5-kg (11-lb) weight loss over the past 3 months. His medical history includes hypertension well-controlled on lisinopril. Vital signs are within normal limits. Physical and neurological examinations reveal no abnormalities. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiate trial of a selective serotonin reuptake inhibitor

Cevap

Initiate trial of a selective serotonin reuptake inhibitor
The patient's clinical picture is classic for major depressive disorder with prominent cognitive impairment, a condition historically termed 'pseudodementia'. Key distinguishing features from a primary neurocognitive disorder (such as Alzheimer disease) include the relatively acute onset following a significant life stressor, the patient's severe distress and retained insight regarding his memory loss, and the characteristic 'I don't know' responses on cognitive testing that improve with encouragement. In true dementia, patients typically have an insidious onset, lack insight (anosognosia), try to conceal their deficits, and genuinely cannot recall information despite encouragement. The presence of vegetative symptoms (weight loss, early morning awakenings) further supports the diagnosis of major depression. The most appropriate next step is to initiate a trial of an antidepressant medication, such as an SSRI.

Adım Adım Çözüm

1
Analyze the onset and nature of the cognitive symptoms.
The cognitive decline had an abrupt onset 4 months ago following a major stressor (spouse's death), and the patient shows significant distress and insight regarding his memory loss.
Differentiating between neurocognitive disorders and psychiatric conditions requires evaluating the timeline, precipitating factors, and the patient's awareness of their deficits.
2
Evaluate the patient's performance on cognitive testing.
The patient gives 'I don't know' answers and displays poor initial effort, but performs adequately with encouragement.
Patients with true dementia typically make genuine attempts to answer but confabulate or fail, whereas patients with depression often show poor effort but intact underlying cognition.
3
Identify the primary underlying pathology.
The combination of depressed mood, weight loss, early morning awakenings, and cognitive complaints points to major depressive disorder (pseudodementia).
Recognizing the somatic and psychological criteria for major depression is necessary to guide treatment.
4
Determine the most appropriate management.
Treating the underlying depression with a selective serotonin reuptake inhibitor (SSRI) is the correct next step.
Reversing the depressive episode will likely resolve the secondary cognitive impairment.

Anahtar Kavram

Major depressive disorder in the elderly can present with prominent cognitive deficits (pseudodementia), which are distinguished from true dementia by the patient's prominent distress over memory loss, poor effort on testing that improves with encouragement, and an acute onset associated with a stressor. The primary treatment is targeted at the underlying depression.
Soru 626Soru →

A 28-year-old pregnant woman, G2P1, at 32 weeks gestation presents to the emergency department complaining of severe muscle aches, abdominal cramps, nausea, and diarrhea for the past 24 hours. She has a history of opioid use disorder and admits to using intranasal heroin daily, but reports she ran out yesterday. She also states she has been feeling profoundly sad, having low energy, and sleeping excessively over the past 3 weeks. Her medical records indicate two previous psychiatric hospitalizations for manic episodes characterized by grandiosity and a decreased need for sleep. Vital signs are temperature 37.2°C (99.0°F), blood pressure 140/90 mm Hg, heart rate 110/min, and respiratory rate 18/min. Physical examination reveals dilated pupils, frequent yawning, rhinorrhea, and piloerection. Fetal heart rate monitoring reveals a baseline of 150/min, moderate variability, positive accelerations, and no decelerations.

The physician counsels the patient on the risks of untreated opioid withdrawal during pregnancy, including preterm labor and fetal demise. The patient demonstrates a clear understanding of these risks but states, "I need to leave right now to take care of my 3-year-old at home. I refuse to be admitted, but I want to get better. I will come to the outpatient clinic tomorrow morning."

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Administer a dose of sublingual buprenorphine and arrange for outpatient follow-up

Cevap

The most appropriate next step in management is to administer a dose of sublingual buprenorphine and arrange for outpatient follow-up.
This patient is experiencing acute opioid withdrawal, which in a pregnant patient poses a significant risk to the fetus, including fetal distress and preterm labor. She has decision-making capacity and has explicitly refused inpatient admission. Because competent pregnant patients have the legal right to refuse medical treatment, the physician cannot force an admission. The most appropriate immediate intervention is to treat her withdrawal to protect both her and the fetus. Administration of sublingual buprenorphine in the emergency department is safe, evidence-based, and effectively relieves withdrawal symptoms. Following stabilization, arranging close outpatient follow-up is the standard of care for a patient who declines hospitalization.

Adım Adım Çözüm

1
Identify the patient's primary acute medical condition.
The patient is experiencing acute opioid withdrawal, evidenced by her history and clinical signs (myalgias, GI distress, dilated pupils, yawning, piloerection).
Recognizing acute withdrawal is critical because untreated withdrawal in a pregnant patient increases the risk of preterm labor, placental abruption, and fetal distress.
2
Determine the standard medical intervention for this condition in pregnancy.
Opioid agonist therapy (such as buprenorphine or methadone) is the standard of care to stabilize maternal opioid levels and protect the fetus.
It prevents withdrawal-induced fetal complications and reduces the risk of illicit substance relapse.
3
Evaluate the legal and ethical constraints regarding the patient's refusal of admission.
The patient clearly understands the risks, demonstrating decision-making capacity. Therefore, she cannot be held involuntarily.
A competent adult, including a pregnant woman, retains the absolute right to refuse medical treatment and hospitalization, regardless of the potential harm to the fetus.
4
Select the course of action that optimizes medical care while respecting patient autonomy.
Initiate sublingual buprenorphine in the emergency department and discharge her with a concrete outpatient follow-up plan.
This provides necessary, evidence-based medical treatment for her acute withdrawal without violating her right to refuse inpatient admission.

Anahtar Kavram

Management of opioid withdrawal in pregnancy and maternal medical autonomy.
Soru 627Soru →

A 28-year-old male with a 5-year history of schizophrenia is evaluated in the inpatient psychiatric unit for severe, persistent commanding auditory hallucinations and paranoid delusions. He is currently prescribed olanzapine 20 mg daily. His psychiatric history reveals a prior 8-week trial of risperidone 6 mg daily, which was discontinued due to a lack of efficacy. The patient insists he takes his medication every day as prescribed. The treatment team is evaluating him for treatment-resistant schizophrenia. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The optimal sequence is: 1) Verify adherence, 2) Obtain baseline ANC and complete REMS registration, 3) Initiate clozapine with slow titration, 4) Monitor ANC weekly for six months, 5) Consider ECT or augmentation for clozapine-refractory symptoms.
The correct sequence follows the standard psychiatric algorithm for suspected treatment-resistant schizophrenia (failure of two antipsychotics). Adherence must be verified first to rule out pseudo-resistance. Once true resistance is established, clozapine is the drug of choice. Due to the risk of life-threatening agranulocytosis, baseline ANC and REMS registration must precede initiation. Clozapine is then started with a slow dose titration, followed by mandatory weekly ANC monitoring for the first six months. If clozapine fails, ECT or augmentation (clozapine-refractory management) is the final step.

Adım Adım Çözüm

1
Rule out pseudo-resistance.
Medication adherence is objectively verified.
Non-adherence is the most common cause of apparent treatment failure in schizophrenia. It must be ruled out before escalating to clozapine.
2
Prepare for clozapine initiation.
Baseline ANC is obtained and REMS registration is completed.
Clozapine carries a black-box warning for severe neutropenia; baseline labs and federal REMS registry enrollment are prerequisites for prescription.
3
Start clozapine pharmacotherapy.
Clozapine is initiated and titrated slowly.
A slow titration schedule is required to mitigate the risk of adverse cardiovascular events and dose-dependent seizures.
4
Maintain clozapine safety monitoring protocols.
Weekly ANC monitoring is conducted for 6 months.
REMS protocol mandates weekly blood draws for the first 6 months to detect agranulocytosis early and ensure patient safety.
5
Address clozapine-resistant schizophrenia.
ECT or augmentation strategies are considered.
If a patient fails clozapine monotherapy, they are considered clozapine-refractory, and more invasive or combinatory treatments are warranted.

Anahtar Kavram

Algorithm for Treatment-Resistant Schizophrenia
Tahmini Süre:1m 30s
Soru 628Soru →

Review the clinical vignettes below, representing adult patients currently undergoing psychiatric evaluation for mood symptoms. Map each individual's unique presentation to the most appropriate initial pharmacological or procedural intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 42-year-old man hospitalized for profound despair, psychomotor agitation, and mood-congruent auditory hallucinations telling him he is 'corrupted from the inside.' He is medically stable, cooperative with nursing staff, and eating adequately.
A 68-year-old man transferred from an assisted living facility due to a 10-day history of mutism, stupor, and absolute refusal to ingest food or fluids, which has now resulted in acute prerenal azotemia and severe dehydration.
A 24-year-old woman with a two-month history of sleeping 14 hours daily, intense carbohydrate cravings, weight gain, and 'leaden' fatigue. She strongly desires medication but specifically requests an option that avoids sexual side effects.
A 28-year-old woman presenting 4 weeks after an uncomplicated vaginal delivery with pervasive anhedonia, insomnia despite infant sleep, and extreme tearfulness. She is exclusively breastfeeding her newborn infant.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings map the medically stable psychotic depression to combined antidepressant/antipsychotic therapy; the life-threatening catatonic depression to ECT; the atypical depression with sexual side-effect concerns to bupropion; and the postpartum depression in a lactating mother to sertraline.
Each correct match strictly aligns with psychiatric treatment guidelines: psychotic features require dual therapy (antidepressant + antipsychotic); severe medical compromise (starvation/dehydration) mandates the rapid, definitive efficacy of ECT; atypical symptoms with an aversion to sexual dysfunction perfectly fit the profile for bupropion; and lactation requires medications with negligible breast milk excretion, like sertraline.

Adım Adım Çözüm

1
Analyze each patient's presenting symptoms to identify the specific depressive subtype or modifying clinical circumstance.
Identified psychotic features, life-threatening catatonia, atypical features with specific side-effect requests, and the postpartum/lactating state.
Major depressive disorder is heterogeneous; treatment choice heavily relies on recognizing these specific modifiers.
2
Select the evidence-based first-line treatment corresponding to each clinical modifier.
Matched each presentation to its respective guideline-directed therapy (e.g., ECT for acute life-threatening situations, Sertraline for lactation safety).
Ensures the chosen intervention maximizes efficacy while minimizing harm for the specific demographic or symptomatic presentation.

Anahtar Kavram

Treatment selection for major depressive disorder subtypes and special populations
Tahmini Süre:1m 30s
Soru 629Soru →

Match each pharmacologic agent used in the treatment of substance use disorders with its corresponding mechanism of action, clinical profile, or key contraindication.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Naltrexone
Acamprosate
Buprenorphine
Methadone
Disulfiram

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Naltrexone matches with the mu-opioid receptor antagonist contraindicated in liver disease. Acamprosate matches with the glutamate modulator contraindicated in severe renal impairment. Buprenorphine matches with the partial agonist that can precipitate withdrawal. Methadone matches with the full agonist associated with QTc prolongation. Disulfiram matches with the aldehyde dehydrogenase inhibitor.
Each medication has distinct pharmacological properties and contraindications. Naltrexone reduces alcohol and opioid cravings but can cause hepatotoxicity. Acamprosate helps maintain alcohol abstinence but is renally cleared. Buprenorphine's partial agonism provides safety against overdose but risks precipitated withdrawal. Methadone is a full agonist requiring QTc monitoring. Disulfiram is an aversive agent that inhibits aldehyde dehydrogenase.

Adım Adım Çözüm

1
Evaluate the clinical profile and contraindications of Naltrexone and Acamprosate for alcohol use disorder.
Naltrexone is hepatically cleared and contraindicated in severe liver disease. Acamprosate is renally cleared and contraindicated in severe renal disease.
Differentiating the first-line therapies for alcohol use disorder based on patient organ function is a critical clinical skill.
2
Analyze the receptor pharmacology of medications for opioid use disorder.
Methadone is a full mu-opioid agonist (risk of QTc prolongation), whereas buprenorphine is a partial agonist.
The partial agonism of buprenorphine creates a ceiling effect for respiratory depression but also causes precipitated withdrawal if administered while full agonists are still bound to receptors.
3
Identify the mechanism of second-line, aversive therapy for alcohol use disorder.
Disulfiram functions by inhibiting aldehyde dehydrogenase.
This mechanism directly leads to acetaldehyde accumulation, causing the intended aversive physical reaction when alcohol is consumed.

Anahtar Kavram

Pharmacotherapy for substance use disorders requires careful selection based on receptor pharmacology (full vs. partial agonists) and medical comorbidities (hepatic vs. renal impairment).
Tahmini Süre:1m 30s
Soru 630Soru →

A 31-year-old male architect is evaluated via a telehealth consultation. Over the past 14 weeks, he has refused to leave his apartment, citing a firm belief that a competing architecture firm has deployed microscopic drones to monitor his thoughts. He frequently hears a male voice criticizing his design choices. The patient's mother reports that roughly coinciding with the onset of the paranoia, the patient experienced a 6-day period where he slept only 3 hours per night, exhibited pressured speech, and impulsively bought $8,000 worth of computer equipment. This hyperactive period spontaneously resolved within a week. Since that time, his paranoid beliefs and auditory hallucinations have remained constant, and his mood has been euthymic. His medical history is unremarkable. A recent urine toxicology screen was negative. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Schizophreniform disorder

Cevap

Schizophreniform disorder
The correct diagnosis is established by the presence of active-phase psychotic symptoms (hallucinations and delusions) that have lasted for more than 1 month but less than 6 months (14 weeks). While the patient experienced a brief 6-day hypomanic episode, it accounted for a very small fraction of the total 14-week illness. Because the mood symptoms were not present for the majority of the active and residual portions of the illness, and the psychosis persisted independently, a primary psychotic diagnosis within the 1-6 month temporal window is required.

Adım Adım Çözüm

1
Identify the core psychiatric symptoms and their severity.
The patient has fixed false beliefs (delusions regarding drones) and auditory hallucinations (voice criticizing designs) leading to severe functional impairment.
Establishing the presence of active-phase psychotic symptoms is the first step in formulating a differential diagnosis.
2
Calculate the exact duration of the psychotic symptoms.
The symptoms began 14 weeks (approximately 3.5 months) ago and are ongoing.
Psychotic disorders are primarily differentiated by their precise duration: less than 1 month, 1 to 6 months, or greater than 6 months.
3
Evaluate the concurrent mood symptoms and their timeline relationship to the psychosis.
The patient had a 6-day hypomanic episode at the onset, but the psychosis has persisted independently for over 13 weeks while the patient was euthymic.
This rules out a primary mood disorder with psychotic features (where psychosis only occurs during the mood episode) and illnesses requiring mood symptoms to be present for the majority of the psychotic illness duration.
4
Synthesize the timeline and symptom profile to select the final diagnosis.
Primary psychosis lasting between 1 and 6 months with only brief, minority-duration mood symptoms meets criteria for schizophreniform disorder.
This aligns perfectly with DSM-5 criteria for this specific temporal window.

Anahtar Kavram

The precise timeline criteria (1 to 6 months) for diagnosing schizophreniform disorder and its differentiation from primary mood disorders based on the independent persistence of psychosis.

Alternatif Yöntem

When evaluating a vignette with both psychotic and mood symptoms, first draw a mental timeline. If the psychosis outlasts the mood episode by more than 2 weeks, it is a primary psychotic disorder. Then, strictly apply the duration criteria to the total time of psychosis (14 weeks = 1-6 month category).
Tahmini Süre:1m 30s
Soru 631Soru →

Accompanied by her husband, a 31-year-old architect presents to her primary care physician with complaints of overwhelming fatigue and persistent low mood that began a month ago. She reports spending most of her days in bed, missing work deadlines, and feeling intensely guilty about her lack of productivity. She states, "I just don't see the point in trying anymore." Upon further questioning, her husband recalls an unusual period two years prior. Over a span of 15 days, the patient barely slept, talked continuously about redesigning their entire city, and impulsively purchased $15,000 worth of construction materials. That episode led to severe financial distress and a brief psychiatric hospitalization, after which she returned to her baseline. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 1.1 mU/L (normal: 0.5–5.0 mU/L) and a free T4 level of 0.9 ng/dL (normal: 0.9–1.7 ng/dL). She currently takes no medications. Which of the following is the most appropriate pharmacotherapy to initiate for this patient?

Cevabı ve açıklamayı göster

Cevap: Quetiapine

Cevap

The most appropriate pharmacotherapy is quetiapine.
The patient's presentation of overwhelming fatigue, persistent low mood, and intense guilt represents a major depressive episode. However, her clear history of a 15-day manic episode (decreased need for sleep, pressured speech, grandiosity, and severe impairment requiring hospitalization) establishes the diagnosis of bipolar I disorder. The first-line treatment for acute bipolar depression includes specific second-generation antipsychotics (e.g., quetiapine, lurasidone, cariprazine) or mood stabilizers (e.g., lithium, lamotrigine). Quetiapine is an FDA-approved monotherapy for acute bipolar depression that effectively targets mood symptoms without the risk of inducing a manic switch.

Adım Adım Çözüm

1
Analyze the patient's current symptoms and past psychiatric history.
Current symptoms indicate a major depressive episode (fatigue, low mood, guilt, anhedonia). The past history of decreased sleep, grandiosity, impulsivity, and hospitalization lasting 15 days indicates a prior manic episode.
Establishing the overarching diagnosis is required to determine the correct pharmacologic treatment algorithm.
2
Synthesize the findings to make a definitive diagnosis.
The combination of at least one lifetime manic episode and a current depressive episode confirms the diagnosis of Bipolar I disorder, current episode depressed.
Differentiating bipolar depression from unipolar major depressive disorder is critical, as the treatments differ significantly and unipolar treatments can be dangerous in bipolar disorder.
3
Select the most appropriate pharmacotherapy for acute bipolar depression.
Quetiapine is selected over antidepressant monotherapy or thyroid replacement.
Quetiapine is an FDA-approved monotherapy for bipolar depression that treats mood symptoms without risking a manic switch. Labs rule out hypothyroidism, and the symptom timeline rules out a primary psychotic disorder.

Anahtar Kavram

The diagnosis of bipolar I disorder is established by the presence of at least one lifetime manic episode. Acute bipolar depression must be treated with specific atypical antipsychotics (e.g., quetiapine, lurasidone) or mood stabilizers, rather than antidepressant monotherapy, to avoid precipitating a manic switch.
Tahmini Süre:1m 30s
Soru 632Soru →

A 1414-year-old boy is brought to the pediatric clinic by his mother due to a 33-month history of declining academic performance, irritability, and social withdrawal. She reports that he frequently locks himself in his room and sometimes appears clumsy and disoriented when she enters abruptly. Physical examination reveals an erythematous, eczematous rash around his mouth and nose. Neurologic examination is significant for a broad-based, unsteady gait, dysarthria, and diminished deep tendon reflexes in the lower extremities. Laboratory studies show:

Laboratory ParameterResultReference Range
Sodium138 mEq/L138 \text{ mEq/L}136136-145 mEq/L145 \text{ mEq/L}
Potassium2.8 mEq/L2.8 \text{ mEq/L}3.53.5-5.0 mEq/L5.0 \text{ mEq/L}
Chloride115 mEq/L115 \text{ mEq/L}9595-105 mEq/L105 \text{ mEq/L}
Bicarbonate14 mEq/L14 \text{ mEq/L}2222-28 mEq/L28 \text{ mEq/L}
Blood urea nitrogen12 mg/dL12 \text{ mg/dL}77-18 mg/dL18 \text{ mg/dL}
Creatinine0.7 mg/dL0.7 \text{ mg/dL}0.60.6-1.2 mg/dL1.2 \text{ mg/dL}

Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Inhalant use disorder

Cevap

The most likely diagnosis is inhalant use disorder, specifically secondary to toluene abuse.
The correct answer is inhalant use disorder, specifically toluene abuse. Toluene is a volatile solvent found in household products such as glues, paint thinners, and aerosols, and is frequently abused by adolescents due to its easy accessibility. Chronic inhalation causes a characteristic constellation of clinical findings. Dermatologically, the drying effects of hydrocarbons often lead to a perioral eczematous dermatitis colloquially known as "glue sniffer's rash." Neurologically, it causes prominent cerebellar signs (e.g., ataxia, dysarthria) and a peripheral neuropathy (manifesting as diminished deep tendon reflexes). Furthermore, toluene toxicity is classically associated with a Type 1 (distal) renal tubular acidosis. This presents laboratory findings of a hypokalemic, hyperchloremic, normal anion gap metabolic acidosis. This patient's calculated anion gap is 9 mEq/L, confirming a normal anion gap acidosis, which perfectly aligns with toluene-induced renal tubular acidosis.

Adım Adım Çözüm

1
Analyze the patient's physical examination findings.
The patient exhibits a perioral eczematous rash, broad-based ataxia, dysarthria, and hyporeflexia.
Identifying specific neurologic and dermatologic signs helps narrow the differential diagnosis among various substances of abuse.
2
Calculate the anion gap and interpret the laboratory results.
The anion gap is calculated as Sodium - (Chloride + Bicarbonate) = 138 - (115 + 14) = 9 mEq/L. This falls within the normal range (8-12 mEq/L). The patient therefore has a normal anion gap (hyperchloremic) metabolic acidosis combined with significant hypokalemia (2.8 mEq/L).
Acid-base status is crucial for distinguishing between different toxicological etiologies, particularly differentiating normal anion gap from high anion gap states.
3
Synthesize the clinical and laboratory data to identify the offending substance.
The combination of a "glue sniffer's rash", cerebellar signs, peripheral neuropathy, and Type 1 (distal) renal tubular acidosis is a pathognomonic presentation for chronic toluene toxicity.
Toluene, found in easily accessible products like glue and paint thinner, directly causes these unique dermatologic, neurologic, and renal manifestations.

Anahtar Kavram

Clinical presentation and laboratory findings of inhalant (toluene) use disorder
Soru 633Soru →

A 29-year-old woman, G1P0 at 16 weeks gestation, is evaluated in the emergency department. She was brought in by her sister after expressing a detailed plan to end her life by carbon monoxide poisoning in her garage. The patient has a 5-year history of bipolar disorder but discontinued all medications 6 months ago. Over the past three weeks, she has exhibited profoundly depressed mood, anhedonia, and hypersomnia. In the emergency department, she is irritable, refuses further psychiatric evaluation, and states, "I have the right to leave. If you try to stop me, I will sue this hospital." The patient's sister presents legally binding documentation designating herself as the patient's healthcare proxy. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Place the patient on an involuntary psychiatric hold

Cevap

The most appropriate next step is to place the patient on an involuntary psychiatric hold.
The patient presents with severe depression and a specific, lethal plan for suicide, placing her at imminent risk of self-harm. In all jurisdictions, physicians have the legal authority and ethical obligation to place such patients on an involuntary psychiatric hold. This emergency action overrides the patient's autonomy, threats of legal action, and the standard surrogate decision-making process. The primary justification is the protection of the patient's life, not the life of the fetus.

Adım Adım Çözüm

1
Assess the patient's risk to self or others.
The patient has a specific, lethal plan for suicide (carbon monoxide poisoning), indicating imminent risk of self-harm.
Imminent risk is the primary threshold for determining the need for involuntary psychiatric intervention.
2
Evaluate the patient's capacity and right to refuse treatment.
The patient's active suicidality secondary to a severe depressive episode deprives her of the capacity to safely refuse admission.
Patients cannot leave against medical advice if they pose an immediate threat to their own life.
3
Determine the appropriate legal and ethical pathway for intervention.
Initiate an emergency involuntary psychiatric hold.
In emergency situations involving imminent danger, standard involuntary hold protocols are executed directly by the physician, superseding standard surrogate decision-making hierarchies, threats of litigation, and pregnancy status.

Anahtar Kavram

Involuntary psychiatric holds are legally and ethically indicated for patients who present an imminent danger to themselves or others, regardless of proxy availability, pregnancy status, or threats of litigation.
Tahmini Süre:1m 30s
Soru 634Soru →

A 66-year-old retired accountant is evaluated in the clinic for a 12-month history of progressive memory impairment. His husband reports that the patient frequently forgets recent conversations, struggles to manage their household finances, and occasionally gets lost in familiar neighborhoods. His past medical history is significant for well-controlled hypertension and hyperlipidemia. Vital signs are within normal limits, and a general physical examination shows no acute abnormalities. The physician suspects a major neurocognitive disorder and plans a comprehensive diagnostic evaluation. Arrange the following diagnostic and evaluative steps in the most appropriate, standard chronological sequence for the workup of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The standard diagnostic sequence begins with objective cognitive screening, followed by laboratory evaluation for reversible causes, structural neuroimaging to assess for cerebrovascular or space-occupying lesions, and finally, advanced functional imaging or biomarker testing if the diagnosis remains unclear.
The evaluation of suspected major neurocognitive disorder is a standardized, step-wise process designed to minimize unnecessary testing while identifying reversible causes. It begins with establishing the presence and severity of cognitive decline using validated bedside screening tools. Once cognitive impairment is objectively confirmed, the next step is to rule out common, reversible metabolic and systemic causes using routine laboratory tests. Following this, structural neuroimaging (preferably an MRI) is obtained to rule out structural lesions (e.g., subdural hematoma, tumors) and cerebrovascular disease, as well as to identify supportive anatomical changes (e.g., hippocampal atrophy). Finally, if the diagnosis remains uncertain and differentiating between specific neurodegenerative diseases is necessary for management, advanced diagnostics such as FDG-PET or cerebrospinal fluid biomarkers are indicated.

Adım Adım Çözüm

1
Confirm and quantify the cognitive impairment.
Administration of a standardized bedside cognitive assessment tool.
Provides an objective baseline and confirms the clinical suspicion of neurocognitive decline before pursuing expensive or invasive testing.
2
Screen for systemic, reversible causes of cognitive decline.
Routine laboratory testing (e.g., vitamin B12, thyroid-stimulating hormone).
Endocrine and metabolic derangements are common, easily treatable etiologies that must be ruled out early in the diagnostic pathway.
3
Evaluate for macroscopic intracranial pathology.
Structural neuroimaging (preferably magnetic resonance imaging).
Identifies occult strokes, tumors, and hydrocephalus, while providing supportive anatomical evidence (e.g., medial temporal lobe atrophy) for neurodegenerative conditions.
4
Differentiate ambiguous neurodegenerative syndromes.
Functional neuroimaging (e.g., FDG-PET) or biomarker analysis.
Utilized only when the initial standard clinical and structural workup is inconclusive, particularly to differentiate between Alzheimer disease and frontotemporal dementia.

Anahtar Kavram

Sequential Diagnostic Evaluation of Major Neurocognitive Disorders
Tahmini Süre:1m 15s
Soru 635Soru →

A 34-year-old male architect is accompanied to the primary care physician by his spouse. The patient survived a severe structural collapse at a building site exactly twenty-four days ago. Since the event, he has experienced recurrent, intrusive nightmares about the collapse and profound distress when exposed to loud noises. He actively avoids visiting any construction zones. The spouse notes that the patient has been highly irritable, jumpy, and disconnected from his family. During the psychiatric review of systems, the physician discovers that six years ago, the patient had a discrete four-week episode characterized by a severely decreased need for sleep, pressured speech, and grandiose delusions that required inpatient psychiatric hospitalization. Current laboratory studies reveal a serum thyroid-stimulating hormone level of 1.8 µU/mL (normal: 0.4-4.5 µU/mL) and a free thyroxine level of 1.2 ng/dL (normal: 0.8-1.8 ng/dL). Which of the following is the most appropriate next step in the management of this patient's condition?

Cevabı ve açıklamayı göster

Cevap: Provision of trauma-focused behavioral psychotherapy

Cevap

Provision of trauma-focused behavioral psychotherapy
The patient is presenting with symptoms characteristic of a trauma-related disorder (intrusions, avoidance, negative mood, arousal) following a life-threatening event. Because the timeline is exactly 24 days (less than one month), the appropriate diagnosis is Acute Stress Disorder (ASD). The first-line recommended treatment for ASD is trauma-focused behavioral psychotherapy (such as trauma-focused cognitive behavioral therapy). This approach is highly effective in reducing current symptoms and preventing the progression to Post-Traumatic Stress Disorder (PTSD). Additionally, psychotherapy is exceptionally safe in this specific patient, who has a clear history of Bipolar I Disorder (evidenced by his prior manic episode with hospitalization) and is currently not taking a mood stabilizer.

Adım Adım Çözüm

1
Evaluate the timeline of the patient's trauma-related symptoms to establish a diagnosis.
The trauma occurred twenty-four days ago. Symptoms of intrusion, avoidance, and hyperarousal lasting less than one month denote Acute Stress Disorder (ASD), not Post-Traumatic Stress Disorder (PTSD).
Accurate psychiatric diagnosis relies heavily on strict timeline criteria defined by the DSM-5.
2
Analyze the patient's psychiatric history for comorbidities.
The history of a four-week episode of decreased sleep, pressured speech, and grandiosity requiring hospitalization indicates a definitive history of Bipolar I Disorder.
Previous psychiatric history directly dictates the safety and selection of current pharmacologic interventions.
3
Determine the most appropriate management based on the diagnosis and psychiatric history.
Trauma-focused cognitive behavioral therapy is the first-line treatment for Acute Stress Disorder. Furthermore, avoiding SSRIs like citalopram is crucial to prevent inducing a manic switch in a bipolar patient.
Psychotherapy is both the gold standard for ASD and completely safe for patients with bipolar disorder who are not currently on mood stabilizers.

Anahtar Kavram

Diagnosis and management of Acute Stress Disorder (ASD) in the context of Bipolar Disorder
Tahmini Süre:1m 15s
Soru 636Soru →

An addiction psychiatry clinic evaluates a 29-year-old male patient who is seeking pharmacological support to maintain abstinence from heroin. The patient states he was discharged from a short-term inpatient detoxification facility 10 days ago and has not used any illicit substances since. Physical examination reveals normal pupillary size, absence of piloerection, and a resting heart rate of 72/min. The physician and patient agree to proceed with an opioid antagonist therapy to reduce the risk of relapse. Arrange the following steps in the most appropriate chronological sequence for safely initiating this patient on long-acting injectable naltrexone.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first verify abstinence with a urine toxicology screen, followed by a naloxone challenge test to rule out physical dependence, then a trial of oral naltrexone for tolerability, and finally the administration of extended-release intramuscular naltrexone.
The initiation of naltrexone therapy requires a strict protocol to ensure patient safety and prevent precipitated withdrawal. The correct sequence is: 1) Objectively verify the required 7 to 14-day abstinence period with a urine drug screen. 2) Perform a naloxone challenge test to ensure the complete resolution of physical dependence (as urine screens may miss some synthetic opioids). 3) Provide a brief oral naltrexone trial to ensure medication tolerability. 4) Administer the long-acting intramuscular formulation for maintenance.

Adım Adım Çözüm

1
Verify abstinence objectively.
A comprehensive urine toxicology screen is ordered and results are negative.
To ensure there has been no recent opioid use, as naltrexone initiation requires a minimum 7 to 14-day opioid-free period to prevent precipitated withdrawal.
2
Confirm the absence of physiological dependence.
A naloxone challenge test is administered, resulting in no withdrawal symptoms.
To definitively prove that the patient is no longer physically dependent on opioids. If dependence was present, the short-acting naloxone would trigger brief withdrawal, signaling that naltrexone cannot yet be given.
3
Assess medication tolerability.
The patient takes oral naltrexone for a few days without adverse effects.
To avoid giving a non-reversible, 4-week depot injection to a patient who might have a severe adverse reaction, such as hepatotoxicity or severe gastrointestinal distress.
4
Initiate maintenance therapy.
Extended-release intramuscular naltrexone is administered.
To provide long-term relapse prevention and opioid receptor blockade, reducing cravings and preventing intoxication if a relapse occurs.

Anahtar Kavram

Initiation protocol for naltrexone maintenance in Opioid Use Disorder
Soru 637Soru →

An emergency physician evaluates a 24-year-old man who collapsed during gymnastics practice. He reports profound weakness and muscle cramps over the past three days. His body mass index is 19.5 kg/m219.5 \text{ kg/m}^2. The patient is heavily preoccupied with his body image and fears gaining weight. He admits to consuming massive amounts of food in short periods, followed immediately by self-induced vomiting, a pattern he repeats several times a day. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 100/60 mmHg100/60 \text{ mmHg}, pulse 105/min105/\text{min}, and respirations 10/min10/\text{min}. Physical examination reveals enlarged parotid glands and calluses on the dorsum of his right hand.

Laboratory results are as follows:

TestResultReference Range
Sodium137 mEq/L136-145 mEq/L
Potassium2.6 mEq/L3.5-5.0 mEq/L
Chloride88 mEq/L98-106 mEq/L
Bicarbonate38 mEq/L22-28 mEq/L
Blood urea nitrogen29 mg/dL8-20 mg/dL
Creatinine1.2 mg/dL0.7-1.3 mg/dL

Arterial blood gas (room air):

ParameterResultReference Range
pH7.537.35-7.45
PaCO2\text{PaCO}_249 mmHg35-45 mmHg
PaO2\text{PaO}_295 mmHg75-105 mmHg

Which of the following best describes this patient's current acid-base status?

Cevabı ve açıklamayı göster

Cevap: Simple metabolic alkalosis with appropriate respiratory compensation

Cevap

Simple metabolic alkalosis with appropriate respiratory compensation
This patient's clinical presentation (binge eating, self-induced vomiting, parotid gland enlargement, calluses on the hand known as Russell sign) is classic for bulimia nervosa. Frequent vomiting results in the loss of gastric hydrochloric acid (HCl), leading to a primary hypochloremic, hypokalemic metabolic alkalosis. This is evidenced by the elevated pH (7.53) and elevated bicarbonate (38 mEq/L). The body naturally compensates for metabolic alkalosis via respiratory hypoventilation to retain carbon dioxide, which drops the respiratory rate (10/min in this patient) and raises the PaCO2.

The expected PaCO2 can be calculated using the formula: Expected PaCO2=40+[0.7×(HCO3−−24)]\text{Expected PaCO}_2 = 40 + [0.7 \times (\text{HCO}_3^- - 24)].
For this patient: 40+[0.7×(38−24)]=40+[0.7×14]=40+9.8=49.8 mmHg40 + [0.7 \times (38 - 24)] = 40 + [0.7 \times 14] = 40 + 9.8 = 49.8 \text{ mmHg}.
The patient's actual PaCO2 of 49 mmHg is consistent with this expected value, indicating a simple (fully compensated) disorder without a superimposed secondary respiratory process.

Adım Adım Çözüm

1
Identify the primary acid-base disorder based on the pH and bicarbonate levels.
The pH is 7.53 (alkalemia) and the bicarbonate is elevated at 38 mEq/L, indicating a primary metabolic alkalosis.
Self-induced vomiting in bulimia nervosa causes a direct loss of gastric hydrochloric acid (HCl), leading to a hypochloremic metabolic alkalosis.
2
Calculate the expected respiratory compensation (expected PaCO2) for the primary metabolic alkalosis.
Using the formula: Expected PaCO2 = 40 + [0.7 * (HCO3 - 24)]. The expected PaCO2 = 40 + [0.7 * (38 - 24)] = 40 + 9.8 = 49.8 mmHg.
To determine whether the patient's respiratory response is appropriate or if there is a superimposed secondary acid-base disorder.
3
Compare the actual PaCO2 to the expected PaCO2.
The patient's actual PaCO2 is 49 mmHg, which perfectly matches the expected physiological compensation range.
Since the actual PaCO2 matches the calculated expectation, the condition is a simple, compensated metabolic alkalosis without any mixed respiratory disorders.

Anahtar Kavram

Patients with bulimia nervosa (purging subtype) frequently develop a hypokalemic, hypochloremic metabolic alkalosis. Accurate diagnosis of their medical complications requires identifying the primary acid-base disorder and calculating the expected respiratory compensation to rule out mixed derangements.
Tahmini Süre:1m 30s
Soru 638Soru →

A 50-year-old woman is diagnosed with major depressive disorder following a period of persistent low mood and anhedonia. Over the next year, her condition progressively worsens despite various treatment attempts, culminating in a state of severe melancholia characterized by a life-threatening refusal to eat and drink. Arrange the following clinical management steps in the correct chronological sequence, representing a standard stepped-care escalation for this patient's evolving clinical condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first initiate SSRI monotherapy, then maximize the dosage of that initial agent, followed by augmenting or switching the medication if response remains poor, and finally administering ECT when life-threatening symptoms emerge.
The stepped-care algorithm for major depressive disorder dictates a sequential escalation of therapies based on clinical response. Treatment begins with an initial trial of an SSRI. If the patient has a sub-optimal response, the immediate next step is to maximize the dose of the current medication to ensure an adequate therapeutic trial. Only after failure of an optimized trial should the clinician proceed to augment the regimen (e.g., with an atypical antipsychotic) or switch to a different class. Ultimately, the development of life-threatening complications, such as the refusal to eat and drink leading to severe physiological compromise, is a primary indication for urgently escalating to electroconvulsive therapy (ECT).

Adım Adım Çözüm

1
Identify the first-line treatment for a new diagnosis of major depressive disorder.
Initiate SSRI monotherapy.
SSRIs are standard initial therapy due to their favorable side-effect profile and established efficacy.
2
Determine the next step if the initial clinical response is inadequate.
Maximize the dosage of the initial SSRI.
An adequate trial requires optimization of the dose and a sufficient duration (4-8 weeks) before declaring treatment failure.
3
Determine the management for continued non-response or partial response after dose optimization.
Augment the regimen with an atypical antipsychotic or switch classes.
When a maximized first-line agent fails, standard algorithms recommend augmentation strategies or switching to alternative agents like SNRIs or bupropion.
4
Identify the definitive treatment for severe, treatment-resistant depression with life-threatening features.
Administer electroconvulsive therapy (ECT).
ECT provides the most rapid and effective response for severe depression complicated by refusal to eat, catatonia, or acute suicidality.

Anahtar Kavram

Stepped-care pharmacological escalation and indications for ECT in Major Depressive Disorder
Tahmini Süre:1m 0s
Soru 639Soru →

A young adult male is brought to the inpatient psychiatric unit by his family due to a profound decline in functioning over the past two weeks. The patient has been entirely mute, persistently holds his arms in rigid, unnatural postures for hours, and refuses all oral intake. His current daily medication regimen includes risperidone and fluoxetine. Vital signs show a heart rate of 105/min105/\text{min} and blood pressure of 130/85 mm Hg130/85\text{ mm Hg}; he is afebrile. The psychiatry team suspects catatonia. Arrange the following management steps in the most appropriate sequential order for evaluating and treating this patient's current condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequential order for managing catatonia is to first discontinue the offending antipsychotic, then perform a lorazepam challenge test, followed by initiating scheduled lorazepam therapy, and finally reserving electroconvulsive therapy for refractory cases.
The standard of care for treating catatonia requires a stepwise approach to maximize safety and efficacy. The absolute first step is the cessation of dopamine-blocking agents (such as risperidone), as these can worsen the catatonic state and provoke neuroleptic malignant syndrome. Once the offending agent is removed, the diagnosis is confirmed and initially treated with a lorazepam challenge. If the patient responds, they are placed on scheduled lorazepam to maintain the therapeutic effect. Electroconvulsive therapy (ECT) is generally reserved as a last-line treatment for medication-refractory catatonia, unless the patient is actively deteriorating with malignant catatonia (fever, autonomic instability), in which case it is used earlier.

Adım Adım Çözüm

1
Identify the diagnosis of catatonia and stop offending agents.
Risperidone is discontinued.
Dopamine antagonists like risperidone can precipitate or worsen catatonia and cross over into neuroleptic malignant syndrome.
2
Perform a diagnostic challenge.
An intravenous lorazepam challenge is administered.
This confirms the diagnosis, as most patients with catatonia will show rapid, albeit temporary, improvement following a dose of intravenous benzodiazepines.
3
Establish a maintenance treatment plan.
Scheduled, high-dose lorazepam is initiated.
Once responsiveness to benzodiazepines is established, standing doses are required to prevent relapse of catatonic symptoms while treating the underlying psychiatric illness.
4
Determine the next step if pharmacological treatment fails.
Electroconvulsive therapy (ECT) is considered.
ECT is highly efficacious but invasive, so it is strictly reserved for patients who do not respond to scheduled benzodiazepines, or those who present with malignant catatonia (severe autonomic instability).

Anahtar Kavram

Stepwise management of catatonia
Soru 640Soru →

A 34-year-old man presents to the clinic with his partner due to a 1-month history of worsening sadness, anhedonia, and sleeping 12 to 14 hours a day. His partner reports that the patient has stopped going to his job as a software developer, barely eats, and has expressed feelings of worthlessness. Medical history is significant for a hospital admission 5 years ago when the patient was found wandering the streets, claiming he was a "prophet" who did not need to sleep, and talking so rapidly that he was difficult to understand. This previous episode resolved after a 2-week inpatient stay, and he eventually stopped taking his prescribed medications. The patient currently exhibits a flat affect and psychomotor retardation. Vital signs are within normal limits, and physical examination shows no abnormalities. Basic metabolic panel and thyroid-stimulating hormone levels are unremarkable. Which of the following pharmacologic therapies are appropriate for this patient's current episode? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Initiate quetiapine; Initiate lurasidone

Cevap

The appropriate pharmacologic therapies for this patient's acute bipolar depression are quetiapine and lurasidone.
This patient has a history of a severe manic episode (grandiosity, decreased need for sleep, pressured speech requiring hospitalization), which establishes the diagnosis of Bipolar I disorder. He is currently experiencing a major depressive episode. First-line, FDA-approved pharmacologic treatments for acute bipolar depression include specific second-generation antipsychotics such as quetiapine and lurasidone. These agents effectively target depressive symptoms without significantly increasing the risk of a manic switch.

Adım Adım Çözüm

1
Analyze the patient's past psychiatric history.
The patient had a previous episode of grandiosity, decreased need for sleep, and rapid speech requiring hospitalization, which meets the criteria for a severe manic episode.
A single manic episode is sufficient to establish the diagnosis of Bipolar I disorder, regardless of current symptoms.
2
Evaluate the current clinical presentation.
The patient presents with sad mood, anhedonia, hypersomnia, decreased appetite, feelings of worthlessness, and psychomotor retardation lasting 1 month.
This constellation of symptoms confirms a current major depressive episode in the context of Bipolar I disorder.
3
Determine the appropriate pharmacotherapy for acute Bipolar I depression.
Appropriate first-line treatments include specific second-generation antipsychotics like quetiapine or lurasidone. Antidepressant monotherapy must be avoided.
Antidepressant monotherapy can precipitate a manic switch in patients with bipolar disorder. Mood stabilizers or specific atypical antipsychotics are indicated to treat the depression safely.

Anahtar Kavram

The treatment of acute bipolar depression requires specific agents such as quetiapine or lurasidone; antidepressant monotherapy is contraindicated due to the severe risk of inducing a manic episode.
Tahmini Süre:1m 15s
ÖncekiSayfa 32 / 41Sonraki
Psychiatry Alıştırma Soruları — USMLE Step 2 CK — Sayfa 32 | Examkin